Inflammation in Prostatic Hyperplasia and Carcinoma-Basic Scientific Approach

Area of Science:

• Urology
• Oncology
• Immunology

Background:

• Chronic inflammation is linked to benign and malignant conditions, including prostate issues.
• Inflammatory cells are prevalent in benign prostatic hyperplasia (BPH) and prostate cancer tissues.
• Prostate inflammation triggers are multifactorial, including bacterial antigens, chemical irritants, and metabolic disorders.

Purpose of the Study:

• To review recent findings and theories on inflammatory responses in the prostate.
• To explore the role of inflammation in both benign and malignant prostate epithelial processes.
• To discuss the dual role of inflammatory cells in prostate cancer progression.

Main Methods:

• Literature review of recent findings and theories.
• Analysis of the role of immunocompetent cells in prostate inflammation.
• Examination of inflammatory pathways and their impact on prostate epithelial cells.

Main Results:

• Inflammatory processes activate hyperproliferative programs, contributing to BPH nodules.
• Inflammation creates a microenvironment conducive to prostate cancer growth and progression.
• Specific inflammatory cells like tumor-associated macrophages can promote tumors, while mast cells may have anti-tumoral effects.

Conclusions:

• Inflammatory responses are key drivers of both benign and malignant epithelial processes in the prostate gland.
• Understanding the complex role of inflammatory cells is crucial for developing targeted therapies.
• Further research is needed to elucidate the precise mechanisms by which inflammation influences prostate health and disease.